nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—L-Carnitine—MPO—atherosclerosis	0.0876	1	CrCbGaD
Methacholine—Pregnancy—Lovastatin—atherosclerosis	0.0454	0.126	CcSEcCtD
Methacholine—Pregnancy—Simvastatin—atherosclerosis	0.0425	0.118	CcSEcCtD
Methacholine—Cough—Rosuvastatin—atherosclerosis	0.0116	0.0323	CcSEcCtD
Methacholine—Cough—Ezetimibe—atherosclerosis	0.00964	0.0268	CcSEcCtD
Methacholine—Chest pain—Lovastatin—atherosclerosis	0.00959	0.0267	CcSEcCtD
Methacholine—Chest pain—Ezetimibe—atherosclerosis	0.0094	0.0262	CcSEcCtD
Methacholine—Chest pain—Simvastatin—atherosclerosis	0.00897	0.025	CcSEcCtD
Methacholine—Syncope—Niacin—atherosclerosis	0.00867	0.0241	CcSEcCtD
Methacholine—Loss of consciousness—Niacin—atherosclerosis	0.0085	0.0237	CcSEcCtD
Methacholine—Cough—Niacin—atherosclerosis	0.00844	0.0235	CcSEcCtD
Methacholine—Cough—Pravastatin—atherosclerosis	0.00831	0.0231	CcSEcCtD
Methacholine—Chest pain—Pravastatin—atherosclerosis	0.00811	0.0226	CcSEcCtD
Methacholine—Shock—Niacin—atherosclerosis	0.00776	0.0216	CcSEcCtD
Methacholine—Pruritus—Rosuvastatin—atherosclerosis	0.00767	0.0214	CcSEcCtD
Methacholine—Hypotension—Niacin—atherosclerosis	0.00737	0.0205	CcSEcCtD
Methacholine—Dizziness—Rosuvastatin—atherosclerosis	0.00717	0.02	CcSEcCtD
Methacholine—Headache—Rosuvastatin—atherosclerosis	0.00679	0.0189	CcSEcCtD
Methacholine—Pruritus—Lovastatin—atherosclerosis	0.0065	0.0181	CcSEcCtD
Methacholine—Nausea—Rosuvastatin—atherosclerosis	0.00644	0.0179	CcSEcCtD
Methacholine—Pruritus—Ezetimibe—atherosclerosis	0.00638	0.0177	CcSEcCtD
Methacholine—Pruritus—Simvastatin—atherosclerosis	0.00608	0.0169	CcSEcCtD
Methacholine—Dizziness—Lovastatin—atherosclerosis	0.00608	0.0169	CcSEcCtD
Methacholine—Dizziness—Ezetimibe—atherosclerosis	0.00596	0.0166	CcSEcCtD
Methacholine—Vomiting—Lovastatin—atherosclerosis	0.00584	0.0163	CcSEcCtD
Methacholine—Headache—Lovastatin—atherosclerosis	0.00576	0.016	CcSEcCtD
Methacholine—Vomiting—Ezetimibe—atherosclerosis	0.00573	0.016	CcSEcCtD
Methacholine—Dizziness—Simvastatin—atherosclerosis	0.00568	0.0158	CcSEcCtD
Methacholine—Headache—Ezetimibe—atherosclerosis	0.00565	0.0157	CcSEcCtD
Methacholine—Pruritus—Niacin—atherosclerosis	0.00558	0.0155	CcSEcCtD
Methacholine—Pruritus—Pravastatin—atherosclerosis	0.0055	0.0153	CcSEcCtD
Methacholine—Vomiting—Simvastatin—atherosclerosis	0.00546	0.0152	CcSEcCtD
Methacholine—Nausea—Lovastatin—atherosclerosis	0.00546	0.0152	CcSEcCtD
Methacholine—Headache—Simvastatin—atherosclerosis	0.00538	0.015	CcSEcCtD
Methacholine—Nausea—Ezetimibe—atherosclerosis	0.00535	0.0149	CcSEcCtD
Methacholine—Dizziness—Niacin—atherosclerosis	0.00522	0.0145	CcSEcCtD
Methacholine—Dizziness—Pravastatin—atherosclerosis	0.00514	0.0143	CcSEcCtD
Methacholine—Nausea—Simvastatin—atherosclerosis	0.00511	0.0142	CcSEcCtD
Methacholine—Vomiting—Niacin—atherosclerosis	0.00502	0.014	CcSEcCtD
Methacholine—Headache—Niacin—atherosclerosis	0.00494	0.0138	CcSEcCtD
Methacholine—Vomiting—Pravastatin—atherosclerosis	0.00494	0.0138	CcSEcCtD
Methacholine—Headache—Pravastatin—atherosclerosis	0.00487	0.0136	CcSEcCtD
Methacholine—Nausea—Niacin—atherosclerosis	0.00469	0.013	CcSEcCtD
Methacholine—Nausea—Pravastatin—atherosclerosis	0.00462	0.0128	CcSEcCtD
Methacholine—CHRM2—GPCR downstream signaling—CNR2—atherosclerosis	0.00109	0.00197	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00109	0.00197	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.00109	0.00197	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—CCL5—atherosclerosis	0.00109	0.00196	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—EDN1—atherosclerosis	0.00108	0.00196	CbGpPWpGaD
Methacholine—CHRM3—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.00108	0.00195	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CASR—atherosclerosis	0.00108	0.00195	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CX3CR1—atherosclerosis	0.00108	0.00195	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—CCL5—atherosclerosis	0.00108	0.00194	CbGpPWpGaD
Methacholine—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.00107	0.00193	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CX3CR1—atherosclerosis	0.00107	0.00193	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CASR—atherosclerosis	0.00107	0.00193	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CX3CL1—atherosclerosis	0.00106	0.00191	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ABCG1—atherosclerosis	0.00105	0.00189	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CX3CL1—atherosclerosis	0.00105	0.00189	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HRH1—atherosclerosis	0.00103	0.00186	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HRH1—atherosclerosis	0.00102	0.00184	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CNR2—atherosclerosis	0.001	0.00181	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CNR2—atherosclerosis	0.000992	0.00179	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—FABP4—atherosclerosis	0.000985	0.00178	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LCAT—atherosclerosis	0.000985	0.00178	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000982	0.00178	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000973	0.00176	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000967	0.00175	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOA4—atherosclerosis	0.000967	0.00175	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP7A1—atherosclerosis	0.00095	0.00172	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000934	0.00169	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—AGT—atherosclerosis	0.000908	0.00164	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—AGT—atherosclerosis	0.000899	0.00163	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP27A1—atherosclerosis	0.000878	0.00159	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCL3—atherosclerosis	0.000861	0.00156	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—EDNRA—atherosclerosis	0.000858	0.00155	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CCR2—atherosclerosis	0.000858	0.00155	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCL3—atherosclerosis	0.000853	0.00154	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CCR2—atherosclerosis	0.000849	0.00154	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000849	0.00154	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—F2—atherosclerosis	0.000839	0.00152	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GHRL—atherosclerosis	0.000836	0.00151	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOA2—atherosclerosis	0.000832	0.0015	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PLA2G2A—atherosclerosis	0.000832	0.0015	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALOX5AP—atherosclerosis	0.000832	0.0015	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALOX15—atherosclerosis	0.000832	0.0015	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—F2—atherosclerosis	0.000831	0.0015	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GHRL—atherosclerosis	0.000828	0.0015	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ABCG5—atherosclerosis	0.000822	0.00149	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOA4—atherosclerosis	0.000808	0.00146	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000806	0.00146	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOA4—atherosclerosis	0.0008	0.00145	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LPA—atherosclerosis	0.000794	0.00143	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EDNRA—atherosclerosis	0.000779	0.00141	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCR2—atherosclerosis	0.000779	0.00141	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000776	0.0014	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCR2—atherosclerosis	0.000771	0.00139	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EDNRA—atherosclerosis	0.000771	0.00139	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000769	0.00139	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—BGN—atherosclerosis	0.000769	0.00139	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOA5—atherosclerosis	0.000761	0.00138	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GHRL—atherosclerosis	0.000759	0.00137	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000754	0.00136	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GHRL—atherosclerosis	0.000752	0.00136	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—CCL2—atherosclerosis	0.000748	0.00135	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL4—atherosclerosis	0.000745	0.00135	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—CCL2—atherosclerosis	0.000741	0.00134	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL4—atherosclerosis	0.000738	0.00133	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—KNG1—atherosclerosis	0.000734	0.00133	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PLA2G1B—atherosclerosis	0.000733	0.00132	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AGTR1—atherosclerosis	0.000729	0.00132	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—KNG1—atherosclerosis	0.000727	0.00131	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000722	0.00131	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALOX5—atherosclerosis	0.000708	0.00128	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOA2—atherosclerosis	0.000696	0.00126	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOA2—atherosclerosis	0.000689	0.00125	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—KNG1—atherosclerosis	0.000666	0.0012	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—UTS2—atherosclerosis	0.000664	0.0012	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AGTR1—atherosclerosis	0.000662	0.0012	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	0.00066	0.00119	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—UTS2—atherosclerosis	0.000657	0.00119	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	0.000656	0.00119	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CX3CR1—atherosclerosis	0.000636	0.00115	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASR—atherosclerosis	0.000636	0.00115	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NAMPT—atherosclerosis	0.000635	0.00115	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LIPC—atherosclerosis	0.000631	0.00114	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	0.00063	0.00114	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASR—atherosclerosis	0.00063	0.00114	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOC3—atherosclerosis	0.000627	0.00113	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CX3CL1—atherosclerosis	0.000624	0.00113	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LDLR—atherosclerosis	0.000623	0.00113	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—EDN1—atherosclerosis	0.000618	0.00112	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	0.000618	0.00112	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CCL5—atherosclerosis	0.000613	0.00111	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	0.000612	0.00111	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CETP—atherosclerosis	0.000608	0.0011	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	0.000608	0.0011	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CNR2—atherosclerosis	0.000592	0.00107	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—CXCL8—atherosclerosis	0.000591	0.00107	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MMP3—atherosclerosis	0.00059	0.00107	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000589	0.00106	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CNR2—atherosclerosis	0.000586	0.00106	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	0.000586	0.00106	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	0.000585	0.00106	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	0.000583	0.00105	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SCARB1—atherosclerosis	0.000583	0.00105	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000578	0.00104	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	0.000561	0.00101	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000557	0.00101	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000556	0.00101	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000552	0.000997	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMGCR—atherosclerosis	0.00055	0.000995	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.00053	0.000957	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000527	0.000953	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000525	0.000948	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000524	0.000947	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000522	0.000944	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.000521	0.000942	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000519	0.000938	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000516	0.000932	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000513	0.000928	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.000509	0.00092	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.000508	0.000919	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000504	0.000911	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ABCA1—atherosclerosis	0.00049	0.000887	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000487	0.000881	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.000482	0.000872	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000474	0.000857	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.00047	0.000849	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.000466	0.000842	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000461	0.000834	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.00046	0.000832	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.00046	0.000832	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000458	0.000828	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000456	0.000824	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000456	0.000824	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000454	0.00082	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000454	0.00082	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000449	0.000812	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000448	0.00081	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000448	0.00081	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000448	0.00081	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000444	0.000803	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000444	0.000803	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000444	0.000803	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000431	0.000778	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000426	0.000771	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000421	0.000761	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.000412	0.000745	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000408	0.000738	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOB—atherosclerosis	0.000403	0.000729	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000394	0.000711	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000392	0.000709	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000391	0.000707	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.00039	0.000704	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000387	0.0007	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LPL—atherosclerosis	0.000385	0.000696	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.000384	0.000694	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.000381	0.000689	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.00038	0.000687	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000378	0.000682	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GPX1—atherosclerosis	0.000375	0.000679	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CD36—atherosclerosis	0.000366	0.000661	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000361	0.000653	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000358	0.000646	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000349	0.00063	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.000347	0.000628	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—atherosclerosis	0.000347	0.000626	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.000345	0.000624	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000344	0.000621	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARA—atherosclerosis	0.00034	0.000614	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000337	0.000609	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000334	0.000604	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000334	0.000603	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.000332	0.0006	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000331	0.000598	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AGT—atherosclerosis	0.000329	0.000595	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000329	0.000595	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.000328	0.000594	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000326	0.000589	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOE—atherosclerosis	0.000323	0.000583	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000322	0.000582	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CAV1—atherosclerosis	0.00032	0.000578	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOA1—atherosclerosis	0.000319	0.000576	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.000319	0.000576	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	0.000313	0.000566	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	0.00031	0.00056	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SPP1—atherosclerosis	0.000305	0.000551	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	0.000303	0.000548	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	0.000302	0.000546	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	0.0003	0.000543	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CG—atherosclerosis	0.000291	0.000526	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	0.000282	0.00051	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARG—atherosclerosis	0.000281	0.000508	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	0.000279	0.000505	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—INS—atherosclerosis	0.000276	0.000498	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGT—atherosclerosis	0.000275	0.000498	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGT—atherosclerosis	0.000273	0.000493	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOE—atherosclerosis	0.00027	0.000488	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LEP—atherosclerosis	0.00027	0.000488	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CAV1—atherosclerosis	0.000267	0.000483	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LEP—atherosclerosis	0.000267	0.000483	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOE—atherosclerosis	0.000267	0.000483	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOA1—atherosclerosis	0.000267	0.000482	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	0.000265	0.000478	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	0.000264	0.000477	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ESR1—atherosclerosis	0.000258	0.000465	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	0.000255	0.000461	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—F2—atherosclerosis	0.000254	0.00046	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALB—atherosclerosis	0.000253	0.000457	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—F2—atherosclerosis	0.000252	0.000455	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	0.000243	0.00044	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NOS3—atherosclerosis	0.000242	0.000437	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	0.000241	0.000436	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	0.000233	0.000421	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	0.000231	0.000417	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INS—atherosclerosis	0.00023	0.000417	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INS—atherosclerosis	0.000228	0.000412	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL2—atherosclerosis	0.000227	0.00041	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	0.000225	0.000406	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	0.000223	0.000403	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTGS2—atherosclerosis	0.000221	0.0004	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	0.000221	0.000399	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	0.000212	0.000383	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	0.00021	0.000379	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	0.000202	0.000365	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	0.0002	0.000362	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	0.000179	0.000324	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	0.000178	0.000321	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	0.000173	0.000313	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	0.000171	0.00031	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	0.00017	0.000308	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	0.000169	0.000305	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	0.000162	0.000293	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	0.000161	0.00029	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	0.00016	0.00029	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	0.000159	0.000287	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	0.000158	0.000285	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	0.000157	0.000284	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	0.000156	0.000282	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	0.000156	0.000281	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	0.000146	0.000263	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	0.000144	0.000261	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	0.000144	0.000261	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	0.000143	0.000258	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	0.000138	0.000249	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	0.000136	0.000247	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	0.000134	0.000242	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	0.000132	0.000239	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKT1—atherosclerosis	0.000111	0.000201	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—atherosclerosis	0.000101	0.000182	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—atherosclerosis	9.97e-05	0.00018	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	9.29e-05	0.000168	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	9.2e-05	0.000166	CbGpPWpGaD
